← brief for 2026-10-13 · Slowing decline

Validation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) Population.

Key takeaways

This study tested a computer model that predicts if kidney disease will get worse. It used data from the DAPA-CKD trial to check if the model works. It shows a link between the model's predictions and real outcomes, but it is not proof of cause. This helps doctors spot high-risk patients early.

Who did this work

Jongs N · Heerspink HJL · Tangri N · Gottschal P · Ferguson TW · Bamforth RJ · Neuen BL

Source

Article · PubMed, CKD progression and prevention · 2026 Oct 13
https://pubmed.ncbi.nlm.nih.gov/42868053/